Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 7;19(2):38-48.
doi: 10.14797/mdcvj.1176. eCollection 2023.

Explant of the Aortic Endograft: Today's Solutions, Tomorrow's Problems

Alan B Lumsden  1
Affiliations
Review

Explant of the Aortic Endograft: Today's Solutions, Tomorrow's Problems

Alan B Lumsden. Methodist Debakey Cardiovasc J. .

Abstract

Type 2 endoleaks remain the Achilles heel of abdominal aortic endografting. They drive imaging costs and repeat intervention. We believe that after two endovascular interventions, patients should be considered for either graft explantation or graft salvage through an open abdominal exploration. Graft explantation has been associated with increased morbidity and mortality but remains necessary in the face of non-correctible type 1a endoleaks, graft failure, or graft infection. In the majority of cases AAA expansion due to persistent type 2 endoleak is the culprit. In this situation, open repair, with oversewing of the lumbar or inferior mesenteric arteries, can be accomplished providing the seal zones and component overall zones are adequate. This approach does not require aortic clamping. We provide detailed descriptions and videos to facilitate the surgeon in performing these complex procedures.

Keywords: abdominal aortic endograft; aneurysm enlargement; graft explantation; type 2 endoleaks.

PubMed Disclaimer

Conflict of interest statement

Alan B. Lumsden receives research support from W. L. Gore & Associates, CorMatrix Cardiovascular, Silk Road Medical, and Cook Medical. He also consults with Boston Scientific, W. L. Gore & Associates, Siemens, Medical Metrics, Nova Signal, Intact Vascular, Karl Storz, Avail Medsystems, AneuMed, Silk Road Medical, Hemostemix, and KOL BioMedical and is a shareholder in Hatch Medical.

References

    1. Lyons OT, Patel AS, Saha P, Clough RE, Price N, Taylor PR. A 14-year experience with aortic endograft infection: management and results. Eur J Vasc Endovasc Surg. 2013. Sep;46(3):306–13. doi: 10.1016/j.ejvs.2013.04.021 - DOI - PubMed
    1. Arnaoutakis DJ, Sharma J, Blackwood S, et al. Strategies and outcomes for aortic endograft explantation. J Vasc Surg. 2019. Jan;69(1):80–85. doi: 10.1016/j.jvs.2018.03.426 - DOI - PubMed
    1. Peralta CP, Casaban MM. Partial Endograft Explantation with Remnant Aortic Body ‘Neo-neck’. Eur J Vasc Endovasc Surg. 2020. Aug;60(2):202. doi: 10.1016/j.ejvs.2020.04.034 - DOI - PubMed
    1. Steenberge SP, Lyden SP, Turney EJ, et al. Outcomes after Partial Endograft Explantation. Ann Vasc Surg. 2016. Feb;31:1–7. doi: 10.1016/j.avsg.2015.09.018 - DOI - PubMed
    1. Staniszewski T, Beyer R, Matsumura J, Morgan C. Partial open conversion with proximal aortic banding and endograft preservation is a safe option for the treatment of persistent type II endoleaks. J Vasc Surg Cases Innov Tech. 2021. Sep 20;7(4):649–653. doi: 10.1016/j.jvscit.2021.08.003 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources